What to Expect in Mounjaro Week 1

Why the 2.5mg starter dose feels underwhelming (and why that is the right outcome

A question our prescribers hear most weeks: "I've done my first injection and I feel almost nothing) is it working?" For most people, the honest answer in week 1 is: yes, it is working, just not yet in the way you are measuring.

The first pen of Mounjaro contains the 2.5mg dose across four weekly injections. That strength was chosen specifically to reduce the chance of nausea and digestive discomfort at the start. It is a lower exposure than the doses that produce meaningful average weight reductions in clinical trials, so expecting dramatic appetite suppression or the scale to move sharply this early sets you up for unnecessary worry. The weight loss picture in week 1 is genuinely modest for most people, and that is expected.

What you should be watching instead: how your body tolerates the injection itself, whether nausea arrives and how quickly it settles, and whether your appetite shifts even slightly. Small signals in week 1 often predict how you will respond as the dose increases over the coming months. The NHS medicines information for tirzepatide sets out the full side-effect profile and what to monitor, and the NHS tirzepatide page is worth bookmarking before you start.

One practical note: slot the pen into the fridge door when you get home, it sits at the right temperature alongside everyday items and is harder to forget when it is visible.

The side effects that are normal in week 1 on Mounjaro, and the ones that are not

Tirzepatide slows gastric emptying, which is part of how it eventually reduces appetite and calorie intake. In the first week, that same mechanism can cause nausea, loose stools, constipation, indigestion, and a general feeling of fullness after very small amounts of food. These effects are usually at their most noticeable in the 24 to 72 hours after the injection, and they tend to ease within a few days for most people.

They can also be barely perceptible. Some people complete week 1 reporting nothing more than slightly less interest in food at dinner. Both experiences fall within the normal range described in the licensed prescribing information.

What is not normal, and should prompt you to seek medical advice: severe, persistent stomach pain that spreads toward your back, with or without vomiting. This pattern could indicate pancreatitis, which the MHRA highlighted in its January 2026 Drug Safety Update on GLP-1 medicines. It is rare, but it is serious. Similarly, signs of a severe allergic reaction (swelling, difficulty breathing, rapid-onset rash) need emergency attention. If something feels significantly wrong rather than just uncomfortable, contact a clinician or call 111 rather than waiting for your next scheduled review.

For the more routine side effects, eating smaller portions, avoiding very fatty or spicy food, and staying well hydrated all help. Your Patient Information Leaflet has the full detail; our FAQs cover the most common practical questions too.

The decision you are actually making in week 1, and how the first injection informs it

Starting Mounjaro is not a one-time decision. It is a series of smaller ones: whether to continue to the next dose, whether a side effect is worth managing or worth discussing with your prescriber, whether the lifestyle changes running alongside the medicine are sustainable. Week 1 is where that decision-making muscle gets its first workout.

Most people who tolerate the 2.5mg dose without significant problems will continue to the 5mg dose at week five, and from there the dose increases roughly every four weeks under prescriber guidance. The trajectory from week 1 to week 12 looks nothing like week 1 itself. If you are curious about how that early period unfolds, how long Mounjaro takes to work covers the timeline in fuller detail.

The clinical trial data that underpins the medicine (reported in the SURMOUNT-1 trial published in the New England Journal of Medicine) involved 2,539 adults and showed average weight reductions of around 20–21% at the 15mg maintenance dose over 72 weeks. Week 1 contributed nothing obvious to that figure. The work happens incrementally, over months, not in a single injection.

If you would like to understand the cost involved in private Mounjaro treatment before committing to the consultation, that page sets out what is included in the price. And by week 2 or 3, most people notice the first genuine appetite changes, what week 2 typically brings and the shift that often happens around week 3 are covered in the pages ahead.

If you are ready to take the next step, speak to our prescribers through a free consultation, reviewed the same day by a real clinician, not software.